Both in Pharmaceuticals
Serina Therapeutics vs Actinium Pharmaceuticals
Over the past year SER returned −61.2% and ATNM returned +3.5%; their daily moves had a correlation of 0.10.
SER −61.2% ATNM +3.5%Growth of $1, one year, split-adjusted
| Metric | SER | ATNM |
|---|---|---|
| Price | $1.94 | $1.48 |
| Market cap | $49.3M | $46.5M |
| Today | +2.65% | −3.27% |
| 1 month | −0.5% | +28.7% |
| 6 months | +6.8% | +31.0% |
| Year to date | +1.4% | +8.8% |
| 1 year | −58.8% | +1.4% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | 100.0% |
| Net margin | — | 79.7% |
| P/E (TTM) | — | 4.1× |
| Price / sales | — | 1.3× |
| Net cash | $19.9M | $36.5M |
| Dividend yield | — | — |
| Volatility (60d) | 78.0% | 90.4% |
| Short % of float | 0.6% | 2.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).